Veratect, the Kirkland, WA-based company that tracks emerging health threats like swine flu, has raised $4.2 million out of $5 million debt financing, according to an amended regulatory filing today. The filing doesn’t say who invested, but the company’s list of directors includes William Savoy, the former manager of billionaire Paul Allen’s Vulcan investment portfolio and Lee Huntsman, the executive director of the Washington Life Sciences Discovery Fund. A spokesperson for the company didn’t immediately respond to a request for comment.
Author: Luke Timmerman
Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.
View all posts by Luke Timmerman
